|
UPF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.56950000000423E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.6920000000551E-06 |
| Normal-vs-Stage2 |
2.43049999999467E-05 |
| Normal-vs-Stage3 |
1.045730E-02 |
| Normal-vs-Stage4 |
1.376080E-02 |
| Stage1-vs-Stage2 |
4.872000E-01 |
| Stage1-vs-Stage3 |
4.036800E-01 |
| Stage1-vs-Stage4 |
8.311600E-01 |
| Stage2-vs-Stage3 |
2.082800E-01 |
| Stage2-vs-Stage4 |
4.915600E-01 |
| Stage3-vs-Stage4 |
7.368000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58788999999881E-05 |
| Normal-vs-AfricanAmerican |
3.467800E-02 |
| Normal-vs-Asian |
2.562200E-01 |
| Caucasian-vs-AfricanAmerican |
5.215200E-01 |
| Caucasian-vs-Asian |
4.504200E-01 |
| AfricanAmerican-vs-Asian |
5.921400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8330999999614E-06 |
| Normal-vs-Female |
1.264760E-01 |
| Male-vs-Female |
1.745710E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.65390000000021E-05 |
| Normal-vs-Extreme_Weight |
9.96909999995133E-07 |
| Normal-vs-Obese |
1.300310E-03 |
| Normal-vs-Extreme_Obese |
6.01940000000134E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.624400E-01 |
| Normal_Weight-vs-Obese |
1.181580E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.486200E-01 |
| Extreme_Weight-vs-Obese |
8.432200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.300800E-01 |
| Obese-vs-Extreme_Obese |
9.978000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.462190E-01 |
| Normal-vs-Age(41-60Yrs) |
5.778500E-02 |
| Normal-vs-Age(61-80Yrs) |
7.48059999500228E-08 |
| Normal-vs-Age(81-100Yrs) |
4.1635999999956E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.725200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.157200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.596200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.623600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.398600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.941600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.586200E-04 |
| Normal-VS-Type2 PRCC |
1.12049999945185E-07 |
| Normal-VS-KIRP CIMP |
3.987200E-01 |
| Normal-VS-Unclassified PRCC |
9.309900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.428500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.320600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.167800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.717300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.589800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.248000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.75039999956206E-08 |
| Normal-vs-N1 |
8.686200E-01 |
| Normal-vs-N2 |
1.830250E-01 |
| N0-vs-N1 |
4.442100E-02 |
| N0-vs-N2 |
2.911400E-01 |
| N1-vs-N2 |
6.168800E-01 |
|
|
